SSY (SSY)
SunLink Health Systems, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 BURLESON GENE E | -- | Withholding/Transfer | 81.6K | -- | Aug 14, 2025 |
| BURLESON GENE E | -- | Withholding/Transfer | 10.0K | -- | Aug 14, 2025 |
 BAILEYS STEVEN J | -- | Withholding/Transfer | 551.2K | -- | Aug 14, 2025 |
| BAILEYS STEVEN J | -- | Withholding/Transfer | 50.0K | -- | Aug 14, 2025 |
| BAILEYS STEVEN J | -- | Withholding/Transfer | 50.0K | -- | Aug 14, 2025 |
| BAILEYS STEVEN J | -- | Withholding/Transfer | 180.0K | -- | Aug 14, 2025 |
| Name | Shares | % | Source |
|---|---|---|---|
 FORD C MICHAEL Director | 49.4K | -- | FORM 4 |
SunLink Health Systems, Inc., established in 1959 and headquartered in Atlanta, Georgia, delivers an array of healthcare products and services across the southeastern United States.
The company's operations are divided into two principal divisions: Healthcare Services and Pharmacy. The Healthcare Services segment oversees an 84-bed community hospital, which incorporates an 18-bed geriatric psychiatry ward, in addition to a 66-bed facility dedicated to extended care and rehabilitation. This division also furnishes information technology support and holds undeveloped land assets. Through its Pharmacy segment, SunLink provides both institutional and retail pharmacy solutions.
It further offers durable medical equipment (DME), including sales and rentals, catering to institutional clients, individuals within institutional environments, and patients requiring home-based care.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
US30d Avg
--
60d Avg
--
90d Avg
--